CVA Family Office’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,149
Closed -$2.9K 1310
2024
Q1
$2.9K Hold
3,149
﹤0.01% 890
2023
Q4
$6.46K Buy
+3,149
New +$8.15K ﹤0.01% 786
2023
Q3
Sell
-3,678
Closed -$17.1K 1011
2023
Q2
$17.1K Hold
3,678
﹤0.01% 643
2023
Q1
$17.1K Hold
3,678
﹤0.01% 618
2022
Q4
$16.6K Sell
3,678
-115
-3% -$742 ﹤0.01% 593
2022
Q3
$69K Hold
3,793
0.02% 300
2022
Q2
$191K Hold
3,793
0.05% 173
2022
Q1
$535K Hold
3,793
0.13% 98
2021
Q4
$649K Sell
3,793
-118
-3% -$44K 0.16% 89
2021
Q3
$1.12M Hold
3,911
0.81% 31
2021
Q2
$1.96M Hold
3,911
0.56% 39
2021
Q1
$1.98M Hold
3,911
0.75% 33
2020
Q4
$1.86M Hold
3,911
1.15% 26
2020
Q3
$1.12M Hold
3,911
0.81% 31
2020
Q2
$747K Hold
3,911
0.61% 36
2020
Q1
$487K Hold
3,911
0.49% 44
2019
Q4
$684K Buy
+3,911
New +$505K 0.63% 36

Other funds holding AMPE

CVA Family Office's AMPE Position: Q2 2024 in Review

CVA Family Office sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 3,149 shares — an estimated $2.9K sold.

CVA Family Office first reported a position in AMPE in Q4 2019 and held it in 17 quarters. The position peaked at $1.98M in Q1 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • CVA Family Office reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • CVA Family Office sold 3,149 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $2.9K.
  • CVA Family Office first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 17 quarters.
  • CVA Family Office's Ampio Pharmaceuticals Inc. position peaked at $1.98M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on CVA Family Office's 13F filing for Q2 2024, filed 10 Jul 2024.